← FDA Drug Approvals (Drugs@FDA)

ATROVENT HFA

NDA · New Drug Application · Sponsor: BOEHRINGER INGELHEIM · Approved 2004-11-17

Drug application

FDA Application #

NDA021527

Application type

New Drug Application

Brand name

ATROVENT HFA

Generic name

IPRATROPIUM BROMIDE

Active ingredients

IPRATROPIUM BROMIDE

Dosage form

AEROSOL, METERED

Route

INHALATION

Marketing status

Prescription

Sponsor

BOEHRINGER INGELHEIM

Manufacturer

Boehringer Ingelheim Pharmaceuticals, Inc.

First approval

2004-11-17

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown